Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.	Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder	Recruiting	Phase 4	2026-09-14		NCT06323824

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alameda Health System	3
Boston Medical Center (BMC)	1
Hennepin Healthcare Research Institute	8
Kaiser Permanente	96
Marshall Health	1
National Institute on Drug Abuse (NIDA)	549
National Institutes of Health (NIH)	667
The Emmes Company, LLC	17
University of California, San Francisco	637
Yale University	458

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hennepin Healthcare Addiction Medicine	Minneapolis	United States	1
Highland Hospital Bridge Clinic at Alameda Health System	Oakland	United States	1
Marshall University Division of Addiction Sciences P.R.O.A.C.T	Huntington	United States	1
Officed Based Addiction Treatment Program, Boston Medical Center	Boston	United States	1
Outpatient Buprenorphine Induction Clinic, University of California, San Francisco	San Francisco	United States	1
Rapid Start Clinic, Kaiser Permanente Colorado	Denver	United States	1